142 related articles for article (PubMed ID: 9892405)
1. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
Kerr S; O'Keeffe G; Kilty C; Doyle S
J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
[TBL] [Abstract][Full Text] [Related]
2. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
Jordan JA
J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
[TBL] [Abstract][Full Text] [Related]
4. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
[TBL] [Abstract][Full Text] [Related]
5. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
Kock WC
J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
[TBL] [Abstract][Full Text] [Related]
6. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M
J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404
[TBL] [Abstract][Full Text] [Related]
7. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
8. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
Gray JJ; Cohen BJ; Desselberger U
J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
[TBL] [Abstract][Full Text] [Related]
9. Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.
Kaikkonen L; Lankinen H; Harjunpää I; Hokynar K; Söderlund-Venermo M; Oker-Blom C; Hedman L; Hedman K
J Clin Microbiol; 1999 Dec; 37(12):3952-6. PubMed ID: 10565913
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG.
Kaikkonen L; Söderlund-Venermo M; Brunstein J; Schou O; Panum Jensen I; Rousseau S; Caul EO; Cohen B; Valle M; Hedman L; Hedman K
J Med Virol; 2001 Jul; 64(3):360-5. PubMed ID: 11424127
[TBL] [Abstract][Full Text] [Related]
11. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
Salimans MM; van Bussel MJ; Brown CS; Spaan WJ
J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
[TBL] [Abstract][Full Text] [Related]
12. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
[TBL] [Abstract][Full Text] [Related]
13. Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
Tolfvenstam T; Lundqvist A; Levi M; Wahren B; Broliden K
Vaccine; 2000 Nov; 19(7-8):758-63. PubMed ID: 11115697
[TBL] [Abstract][Full Text] [Related]
14. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen.
Brown CS; van Bussel MJ; Wassenaar AL; van Elsacker-Niele AM; Weiland HT; Salimans MM
J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
16. Chemiluminescence Western blot assay for the detection of immunity against parvovirus B19 VP1 and VP2 linear epitopes using a videocamera based luminograph.
Manaresi E; Pasini P; Gallinella G; Gentilomi G; Venturoli S; Roda A; Zerbini M; Musiani M
J Virol Methods; 1999 Aug; 81(1-2):91-9. PubMed ID: 10488766
[TBL] [Abstract][Full Text] [Related]
17. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system.
Brown CS; Salimans MM; Noteborn MH; Weiland HT
Virus Res; 1990 Mar; 15(3):197-211. PubMed ID: 2188463
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1.
Musiani M; Manaresi E; Gallinella G; Venturoli S; Zuffi E; Zerbini M
J Med Virol; 2000 Mar; 60(3):347-52. PubMed ID: 10630969
[TBL] [Abstract][Full Text] [Related]
19. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
Nunoue T
Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
[TBL] [Abstract][Full Text] [Related]
20. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
Corcoran A; Doyle S; Waldron D; Nicholson A; Mahon BP
J Virol; 2000 Nov; 74(21):9903-10. PubMed ID: 11024117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
